Summary We examined the expression of basic fibroblast growth factor (FGF) 
Members of the fibroblast growth factor (FGF, or heparinbinding growth factor) family are potent mitogens for a wide variety of mesodermal and neuroectodermal cells and have been isolated from a variety of tissue and cell sources including tumour cells (Thomas and Gimenetz-Gallego, 1986 ; Gospodarowicz et al., 1987) . To date, at least nine members have been identified from both normal and tumour tissues, including basic FGF, acidic FGF, the int-2 gene product (FGF-3), Kaposi FGF (FGF-4), FGF-5, FGF-6, keratinocyte growth factor (FGF-7), androgen-induced growth factor, and FGF-9 (Klagsburn, 1989; Tanaka et al., 1992; Miyamoto et al., 1993) .
Basic FGF is thought to induce fibrosis, angiogenesis, and tumour progression in human gastric carcinomas, renal cell carcinomas, brain tumours, and malignant melanoma through an autocrine mechanism (Becker et al., 1989; Takahashi et al., 1990; Zagzag et al., 1990; Tanimoto et al., 1991; Eguchi et al., 1992) . Pancreatic carcinomas exhibit strong stromal reactions, or desmoplasia, and have an aggressive behaviour and poor prognosis . Therefore, it is feasible that basic FGF is the factor responsible for desmoplasia and cancer cell proliferation in pancreatic carcinomas. This hypothesis is supported by a study in which basic FGF expression was detected in two human pancreatic carcinoma cell lines (Beauchamp et al., 1990) . A recent study Leung et al., 1994) has also demonstrated the overexpression of basic FGF in human pancreatic carcinoma tissues. In addition, pancreatic carcinoma cells overexpress the FGF receptor which possesses intrinsic tyrosine kinase activity, raising the possibility that the abundance of basic FGF and its receptor may provide human pancreatic carcinoma cells with a considerable growth advantage Leung et al., 1994) . However, the tissue localisation of basic FGF and its receptor proteins have not been fully elucidated in human pancreatic carcinomas.
We examined the immunohistochemical localisation of basic FGF and its receptor in human pancreatic carcinomas and normal pancreatic tissues at the light and electron mic-roscopic level, and determined the relevance of this growth factor system to malignant transformation and clinical parameters including prognosis.
Materials and methods
Patients and tissue specimens The present study included 32 pancreatic ductal adenocarcinomas surgically resected between 1987 and 1993. All tumours were histologically proven to be pancreatic invasive tubular and/or papillary adenocarcinoma. There were no periampullary tumours or distal bile duct tumours not originating from the pancreatic duct. The patients were 22 men and ten women, ranging from 32 to 77 years of age, with a mean age of 63 years. Normal pancreatic tissues were obtained from two male and three female patients undergoing surgery for gastric cancer with combined resection of the distal pancreas and spleen. The resected specimens with attached peripancreatic lymph nodes and neural plexuses were routinely fixed in 10% neutral-buffered formalin and embedded in paraffin, and cut into 5 mm stepwise tissue sections. Histological findings were evaluated according to the General Rules for Cancer of the Pancreas proposed by the Japanese Pancreatic Society (1986). All of the patients on the study were followed until December 1993. Four patients died within 60 days after surgery because of sepsis and hepato-renal failure, and 22 patients relapsed with carcinoma of the pancreas and died from progressive disease in the liver and/or peritoneum. Two patients died of other or unknown causes and four patients survived.
Three or more representative sections, including areas of associated chronic pancreatitis adjacent to the carcinoma, were used for immunohistochemical staining as described below. In addition, in two selected cases, parallel samples were fixed immediately with 4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.2, for 4 h. The tissue blocks were further rinsed overnight in a phosphate buffer containing 20% sucrose, then cut into 15-20 tm sections on a cryostat and mounted on poly-L-lysine-coated glass slides for immunoelectron microscopy of basic FGF.
Antibodies
Monoclonal antibody against human basic FGF was obtained and purified as described previously (Matsuzaki et al., 1989; Yoshitake et al., 1991) . This antibody is highly specific for basic FGF from human, bovine and rodent sources, and does not cross-react with acidic FGF. The anti-FGF receptor antibody was a polyclonal antibody raised in rabbits against purified human recombinant FGF receptor (Flg-5) extracellular domain (Austral Biologicals, CA, USA). This polyclonal antibody recognises recombinant human FGF receptor as evidenced by Western analysis (Figure 1 ).
Light microscopic immunohistochemistry
Immunohistochemistry was performed using a three-step indirect immunoperoxidase method (streptavidin-biotinperoxidase complex) as previously reported (Hughes and Hall, 1993) with a slight modification. Briefly, 4 tm sections were mounted on poly-L-lysine-coated glass slides, air-dried, and deparaffinised with graded xylene and alcohol. For basic FGF staining, protease digestion was carried out using protease K (Boehringer Mannheim Biochemica, Germany) at a concentration of 40 .Lm ml-' for 5 min at 37°C to facilitate penetration of the primary antibody. Following a phosphatebuffered saline (PBS) rinse, the sections were immersed in absolute methanol containing 0.3% hydrogen peroxide to block endogenous peroxidase activity, and incubated with normal goat serum at a 1:30 dilution for 30 min at room temperature to block non-specific binding. Each primary antibody was diluted in PBS/0.3% bovine serum albumin and used at the predetermined optimal dilution (10 fg ml-').
After overnight incubation at 4°C, the sections were rinsed in PBS and incubated for 1 h at room temperature with a biotinylated goat anti-mouse or goat anti-rabbit IgG kDa 200 (Dakopatts, Copenhagen, Denmark ing categories: no staining (-), weak staining (W), and strong staining (S). To determine the relationship between the overexpression of basic FGF or the FGF receptor and the biological behaviour of invasive ductal adenocarcinoma of the pancreas, the 32 patients were classified into two groups according to the proportion of positively stained tumour cells: group 1, patients with no staining or with less than 25% positive tumour cells (low-expression group); group 2, patients with more than 25% positive tumour cells (highexpression group).
Electron microscopic immunocytochemistry Sections immunostained using the three-step indirect immunoperoxidase method described above were post-fixed with 0.5% osmium tetroxide for 20 min at room temperature. After block-staining with uranyl acetate, the sections were dehydrated in graded ethanol, embedded in Epon 812, and cut into ultrathin sections.
Statistical analysis Statistical comparisons on baseline data between the two groups were performed by the chi-square test. The cumulative survival rate was calculated by the Kaplan-Meier method. This was done under the consideration that the number of cases in each group was not large. Statistical analysis of differences between the two groups was made by the log-rank test. The difference was considered to be significant when P < 0.05. (Figure 2a ). Relatively weak cytoplasmic staining of some intralobular and interlobular duct cells was also seen. However, immunostaining was rarely present in islet cells or stromal cells.
Nineteen of the 32 pancreatic ductal adenocarcinomas (59.4%) showed minimal to marked immunoreactivity for basic FGF (Table I) . Eleven of the 19 positively stained tumours exhibited cytoplasmic immunoreactivity ( Figure  3a,b) , while the other eight showed predominantly nuclear immunoreactivity, a phenomenon which was not observed in the normal pancreas (Figure 3c) . Twelve of the adenocarcinomas (40.6%) showed little or no immunostaining in the carcinoma cells. However, intense basic FGF immunoreactivity was seen in many surrounding stromal cells including fibroblasts and macrophages (Figure 3d ). In areas of associated chronic pancreatitis, there was a considerable increase in basic FGF immunoreactivity in the atrophied acinar and ductal cells in comparison with normal pancreas. (Figure 2b ). However, there was no staining in the acinar cells, islet cells or surrounding stromal cells.
Thirty of the 32 pancreatic ductal adenocarcinomas (93.8%) showed minimal to marked immunoreactivity for FGF receptor (Table I ). The staining intensity in the tumours varied from specimen to specimen, as well as from area to area within the same specimen. In these positive cells, FGF receptor was found on both the cell surface and in the cytoplasm, and was especially prominent at the apical surfaces (Figure 4 ). There was no or only weak immunostaining in the stromal cells surrounding the carcinoma cells. However, in some cases, stromal cells in the infiltrative margin of the tumours showed moderate to strong immunoreactivity. In the area of associated chronic pancreatitis, there was a considerable increase in FGF receptor immunoreactivity in the atrophied acinar and ductal cells in comparison with a normal pancreas.
Immunoelectron microscopy for basic FGF Most spindle-shaped cells positive for basic FGF were identified as fibroblasts (Figure 5a ). The immunoreactivity for basic FGF was located in the cytosol (cytoplasmic matrix), and was especially prominent in the cytosol adjacent to the rough endoplasmic reticulum. Carcinoma cells also showed basic FGF immunoreactivity in the cytosol and rarely in the rough endoplasmic reticulum and Golgi apparatus ( Figure Sb) . No distinct staining was detected in the nucleus in the two specimens examined. (Table II) . In contrast, significant difference in retroperitoneal invasion (P< 0.05), lymph node metastasis (P<0.05), and tumour stage (P<0.01) was found between the low and high FGF receptor groups (Table II) .
Survival analysis Survival data were available for 28 of the 32 patients. There was no significant difference in post-operative survival between the low and high basic FGF expression groups ( Figure 6 ). In contrast, low FGF receptor expression was associated with longer post-operative survival as compared with high FGF receptor expression and this difference was statistically significant (P<0.01), although the low FGF receptor expression group represented only a small subgroup of the total population (Figure 7 ).
Discussion
The detection of small pancreatic cancers in Japan has been increasing with improvements in diagnostic methods and the a b Figure 5 Immunoelectron micrograph for basic FGF in human pancreatic ductal adenocarcinoma. (a) Immunoreactivity in a fibroblast adjacent to carcinoma cells is mainly located in the cytosol adjacent to the rough endoplasmic reticulum (x 8800); (b) Carcinoma cell with intense immunoreactivity in the cytosol, and rarely in the rough endoplasmic reticulum and Golgi apparatus (x 16000). discovery of tumour markers for pancreatic cancer (Ariyama et al., 1990; Satake et al., 1991) . However, even if pancreatic ductal adenocarcinomas, excluding an intraductal variant of mucin-producing pancreatic tumour (Morohoshi et al., 1989) , are detected early and completely resected, the incidence of recurrence after pancreatectomy is high and the prognosis is poor Ohta et al., 1993) . This may be due to the aggressive biological behaviour of this cancer.
Recently, various prognostic factors for pancreatic cancers, including DNA nuclear content analysis, argyrophilic nucleolar organiser region (Ag-NOR) counts, and the presence or absence of overexpression of various protooncogenes, growth factors, and their receptors have been investigated. However, there have been only a few reports of reliable prognostic factors for pancreatic cancers (Alanen et al., 1990; Motojima et al., 1991; Tian et al., 1992; Nakamori et al., 1993) . Therefore, it is essential to examine resected specimens for features that might correlate with survival. These features, if identified, would be a guide to prognosis after operation.
Basic FGF has been implicated in tumour angiogenesis through its ability to stimulate the growth of endothelial cells (Folkman and Klagsburn, 1987) . Additionally, this growth factor stimulates fibroblast and epithelial cell growth (Rizzino et al., 1986; Ristow and Messmer, 1988) . Basic FGF mediates its biological effects by binding to a high-affinity cell surface receptor (FGF receptor) containing an intracellular tyrosine kinase domain (Fresel et al., 1986; Olwin and Hauschka, 1989; Klagsburn and Baird, 1991) . Schweigerer et al. (1987b) reported that basic FGF is an autocrine growth factor for human embryonal rhabdomyosarcoma cells. In addition, human gastric cancers, gliomas, meningiomas and renal cell carcinomas have been reported to express basic FGF mRNA (Takahashi et al., 1990; Zagzag et al., 1990; Tanimoto et al., 1991; Eguchi et al., 1992) , and Kaposi's sarcoma cells have been reported to release basic FGF into their medium (Ensoli et al., 1989) . However, basic FGF lacks a typical signal peptide region which facilitates secretion (Gospodarowicz et al., 1987) and its release mechanism remains unknown. Cell lysis or leakage may be involved in the release of basic FGF as the existence of similar mechanisms has been proposed for interleukin-1, another growth factor that lacks a signal peptide (Auron et al., 1984; March et al., 1985; Schweigerer et al., 1987a; Lemoine et al., 1993) .
Previous studies have demonstrated that human pancreatic carcinoma cell lines overexpress basic FGF and the FGF receptor (Beauchamp et al., 1990; Lemoine et al., 1993) . In addition, a recent study has indicated that there are increased levels of basic FGF and FGF receptor in human pancreatic cancers as compared with normal human pancreatic tissues, using immunohistochemical staining, northern blotting, and in situ hybridisation Yamanaka et al., 1993; Leung et al., 1994) . In the present study, we demonstrated the presence of basic FGF and FGF receptor expression in human pancreatic cancers and normal pancreatic tissues by immunocyto-and immunohistochemistry. In the normal pancreas, moderate to marked basic FGF immunoreactivity was present in a heterogeneous pattern at the basal aspect of acinar cells, and intense cytoplasmic FGF receptor immunoreactivity was seen in intralobular, interlobular and main pancreatic duct cells. Additionally, in the human pancreatic cancers minimal to marked basic FGF immunoreactivity was noted in 19 (59.4%) of the 32 tumours and 30 (93.8%) tumours showed minimal to marked cytoplasmic staining for FGF receptor. This suggests that there is concomitant expression of basic FGF and FGF receptor in pancreatic ductal adenocarcinomas, which may allow for excessive autocrine growth stimulation. Furthermore, eight (25%) tumours had nuclear staining for basic FGF, supporting the concept of an intracellular stimulating effect like that of sis protein (Yamamoto et al., 1991; Nakanishi et al., 1992) , i.e. the presence of basic FGF protein in the nucleus has raised the possibility of specific nuclear functions for this molecule in addition to signalling at the cell surface (Mason, 1994 Follow-up (months) studies suggesting the importance of contacts between tumour cells and fibroblasts (Tanaka et al., 1988; Coucke et al., 1992; Gartner et al., 1992) . In the present study, high levels of FGF receptor expression was associated with the presence of retroperitoneal invasion and lymph node metastasis, and with advancing tumour stage, although no statistically significant difference in variable clinicopathological factors was found between the low and high basic FGF expression groups. In addition, low FGF receptor expression was significantly associated with longer post-operative survival, whereas there was no significant difference in post-operative survival between the low and high basic FGF expression groups. Thus, overexpression of FGF receptor may prove to be a more useful prognostic marker than basic FGF expression in pancreatic cancer patients. However, a recent study has shown that overexpression of basic FGF is associated with poor prognosis, although almost all the patients had a poor prognosis and died within 3 years of surgery. Further studies with a large number of patients, including a multivariate analysis, are needed to determine whether expression of basic FGF or of the FGF receptor is a better prognostic marker for patients with completely resected adenocarcinoma of the pancreas.
